Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease

被引:0
作者
Hua Zhang
Kok Pin Ng
Joseph Therriault
Min Su Kang
Tharick A. Pascoal
Pedro Rosa-Neto
Serge Gauthier
机构
[1] the First Affiliated Hospital of Chongqing Medical University,Department of Neurology
[2] National Neuroscience Institute,Department of Neurology
[3] McGill University,The McGill University Research Centre for Studies in Aging
来源
Translational Neurodegeneration | / 7卷
关键词
Alzheimer’s disease; Amyloid-β; Chitinase-3-like protein 1; Phosphorylated tau; Visinin-like protein-1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 159 条
[1]  
Blennow K(2006)Alzheimer’s disease Lancet 368 387-403
[2]  
de Leon MJ(2010)Neuropathology of Alzheimer’s disease Mt Sinai J Med 77 32-42
[3]  
Zetterberg H(2016)A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers Neurology 87 539-547
[4]  
Perl DP(2017)Specific protein biomarker patterns for Alzheimer’s disease: improved diagnostics in progress EPMA J 8 255-259
[5]  
Jack CR(2014)Cerebrospinal fluid analysis in Alzheimer’s disease: technical issues and future developments J Neurol 261 1234-1243
[6]  
Bennett DA(2015)Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer’s disease J Alzheimers Dis 43 1031-1037
[7]  
Blennow K(2013)CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer’s disease and dementia with Lewy bodies J Neurochem 127 681-690
[8]  
Carrillo MC(2011)Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease Ann Neurol 70 274-285
[9]  
Feldman HH(2012)CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease Neurology 78 709-719
[10]  
Frisoni GB(2016)Predictive value of cerebrospinal fluid visinin-like protein-1 levels for Alzheimer’s disease early detection and differential diagnosis in patients with mild cognitive impairment J Alzheimers Dis 50 765-778